Total Payments
$7,571
2024 Payments
$1,284
Companies
34
Transactions
272
Medicare Patients
3,213
Medicare Billing
$664,593
Payment Breakdown by Category
Food & Beverage$7,246 (95.7%)
Consulting$168.22 (2.2%)
Education$156.67 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,246 | 266 | 95.7% |
| Consulting Fee | $168.22 | 1 | 2.2% |
| Education | $156.67 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,272 | 32 | $0 (2024) |
| Amgen Inc. | $909.51 | 27 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $730.52 | 39 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $538.00 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $404.43 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $397.22 | 14 | $0 (2024) |
| Relypsa, Inc. | $256.88 | 10 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $225.64 | 8 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $225.04 | 11 | $0 (2024) |
| Vifor Pharma, Inc. | $203.93 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,284 | 51 | Amgen Inc. ($289.08) |
| 2023 | $941.21 | 40 | Bayer Healthcare Pharmaceuticals Inc. ($175.77) |
| 2022 | $1,152 | 45 | AstraZeneca Pharmaceuticals LP ($283.58) |
| 2021 | $1,436 | 38 | AstraZeneca Pharmaceuticals LP ($654.39) |
| 2020 | $684.84 | 23 | AstraZeneca Pharmaceuticals LP ($177.82) |
| 2019 | $545.88 | 26 | Otsuka America Pharmaceutical, Inc. ($158.26) |
| 2018 | $647.84 | 24 | Amgen Inc. ($239.25) |
| 2017 | $880.33 | 25 | Amgen Inc. ($210.75) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.64 | General |
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Nephrology | ||||||
| 11/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $19.15 | General |
| 10/30/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Rare Disease | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Hyperkalemia | ||||||
| 08/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEPHROLOGY | ||||||
| 08/06/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardio-renal | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEPHROLOGY | ||||||
| 06/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 816 | 1,737 | $376,295 | $181,803 |
| 2022 | 10 | 810 | 1,608 | $311,850 | $144,359 |
| 2021 | 9 | 809 | 2,009 | $382,045 | $181,566 |
| 2020 | 8 | 778 | 1,837 | $338,565 | $156,866 |
Total Patients
3,213
Total Services
7,191
Medicare Billing
$664,593
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 169 | 659 | $78,960 | $42,341 | 53.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 51 | 145 | $73,950 | $41,841 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 357 | $57,120 | $30,518 | 53.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 164 | 178 | $53,400 | $24,726 | 46.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 76 | $28,500 | $13,241 | 46.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 78 | $14,040 | $7,612 | 54.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 39 | 129 | $38,700 | $7,536 | 19.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 23 | $11,730 | $5,525 | 47.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $11,250 | $4,947 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 33 | $7,920 | $3,403 | 43.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 29 | 29 | $725.00 | $114.26 | 15.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 155 | 590 | $70,680 | $34,803 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 403 | $64,480 | $33,567 | 52.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 155 | 170 | $51,000 | $27,535 | 54.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 46 | 46 | $23,460 | $13,579 | 57.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 36 | 150 | $45,000 | $9,044 | 20.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 26 | 50 | $18,750 | $8,887 | 47.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 46 | 46 | $17,250 | $7,702 | 44.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 79 | $14,220 | $6,697 | 47.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 24 | $5,760 | $2,346 | 40.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 50 | 50 | $1,250 | $199.12 | 15.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 174 | 766 | $91,920 | $45,492 | 49.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 219 | 431 | $68,960 | $42,440 | 61.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 168 | 192 | $57,600 | $31,252 | 54.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 36 | 136 | $51,000 | $24,054 | 47.2% |
About Dr. Daniel Lin, M.D
Dr. Daniel Lin, M.D is a Specialist healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104887421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lin, M.D has received a total of $7,571 in payments from pharmaceutical and medical device companies, with $1,284 received in 2024. These payments were reported across 272 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,246).
As a Medicare-enrolled provider, Lin has provided services to 3,213 Medicare beneficiaries, totaling 7,191 services with total Medicare billing of $664,593. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Doylestown, PA
- Active Since 03/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1104887421
Products in Payments
- LOKELMA (Drug) $761.96
- FARXIGA (Drug) $491.97
- Veltassa (Drug) $460.81
- SAMSCA (Drug) $424.57
- Kerendia (Drug) $404.43
- Parsabiv (Biological) $398.93
- INJECTAFER (Drug) $397.22
- JYNARQUE (Drug) $395.42
- ACTHAR (Biological) $382.59
- TAVNEOS (Drug) $289.08
- LUPKYNIS (Drug) $225.04
- JARDIANCE (Drug) $184.47
- IBSRELA (Drug) $150.19
- BENLYSTA (Biological) $145.63
- TARPEYO (Drug) $144.16
- ELIQUIS (Drug) $130.45
- SOLIRIS (Drug) $115.25
- Parsabiv (Drug) $111.88
- KRYSTEXXA (Biological) $110.29
- Sensipar (Drug) $109.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Doylestown
Dr. Alan Chang, Md, MD
Specialist — Payments: $14,797
Specialist $14,797
Mr. Kieran Cody, M.d, M.D
Specialist — Payments: $12,112
Specialist $12,112
Melchiore Vernace, M.d, M.D
Specialist — Payments: $8,914
Specialist $8,914
Dr. Kevin Fitzgerald, M.d, M.D
Specialist — Payments: $6,732
Specialist $6,732
Dr. Louis Morsbach, M.d, M.D
Specialist — Payments: $6,358
Specialist $6,358
Dr. Albert Ruenes, M.d, M.D
Specialist — Payments: $5,785
Specialist $5,785